no abnormal phenotype detected_Egfr<wa2>/Egfr<wa2>,Ereg<tm1Dwt>/Ereg<tm1Dwt>

http://metadb.riken.jp/0002169I129S6SvEvTacEgfrwa2Egfrwa2Eregtm1DwtEregtm1DwtEregtm1DwtEgfrwa2

no abnormal phenotype detected_Egfr<wa2>/Egfr<wa2>,Ereg<tm1Dwt>/Ereg<tm1Dwt>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• epiregulin
  http://metadb.riken.jp/db/mgi_rdf/MGI:107508
• epidermal growth factor receptor
  http://metadb.riken.jp/db/mgi_rdf/MGI:95294

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Egfr<wa2>/Egfr<wa2>,Ereg<tm1Dwt>/Ereg<tm1Dwt>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Ereg<tm1Dwt>|Egfr<wa2>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S6/SvEvTac

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• no abnormal phenotype detected
  http://purl.obolibrary.org/obo/MP_0002169

文献

http://purl.org/net/cito/citesAsAuthority

• Daekee. Lee, et.al., Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage., Molecular and cellular biology, 2004, 24
  http://rdf.ncbi.nlm.nih.gov/pubmed/15456865